2-Amino-3-methylphenol | CAS:2835-97-4

We serve 2-Amino-3-methylphenol CAS:2835-97-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Amino-3-methylphenol

Chemical Name:2-Amino-3-methylphenol
CAS.NO:2835-97-4
Synonyms:2-Hydroxy-6-methylanilin
2-Amino-m-cresol
Phenol, 2-amino-3-methyl-
amino-3-methylphenol
 
Molecular Formula:C7H9NO
Molecular Weight:123.15200
 
Physical and Chemical Properties:
Density:1.157;
Melting point:149-152oC;
Boiling point:240oC;
Flash point:98.9oC;
Index of Refraction:1.688;
 
Specification:
Appearance:Yellow brown crystalline powder
Purity(HPLC):≥99.0%
Ash:≤0.5%
Loss on drying:≤0.5%
Fe content:≤100ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate



Contact us for information like 2-Amino-3-methylphenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,amino-3-methylphenol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Phenol, 2-amino-3-methyl- Use and application,2-Amino-m-cresol technical grade,usp/ep/jp grade.


Related News: ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.1-BROMO-2-FLUORO-4-IODOBENZENE manufacturer Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days.4-Fluorobenzonitrile supplier Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days.2-Hydroxy-6-methylpyridine vendor Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.